Nova Patents
AT404522T

Lipoxin compounds and their use in treating cell proliferative disorders

Abstract

This record has no abstract on file.

Term

Term ended

Expired 15 September 2017, 9 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

77 members in 11 offices

This recordMember, by publication datePriority claim1 more office is in the list below

Priority claims1

Priority claims
DocumentOfficeKindDate
71261096United States of AmericaA

Members77

Family members, oldest first
DocumentOfficeKind
CA2164951A1CanadaA1
CA2448302A1CanadaA1
WO9429262A1World Intellectual Property Organization (WIPO)A1
AU7110994AAustraliaA
US5441951AUnited States of AmericaA
EP0703897A1European Patent Office (EPO)A1
JPH08512023AJapanA
US5648512AUnited States of AmericaA
CA2265708A1CanadaA1
WO9811049A1World Intellectual Property Organization (WIPO)A1
AU4271097AAustraliaA
AU692453B2AustraliaB2
EP0927150A1European Patent Office (EPO)A1
US6048897AUnited States of AmericaA
AU723321B2AustraliaB2
JP2001500866AJapanA
US2001031882A1United States of AmericaA1
US6316648B1United States of AmericaB1
US2002010351A1United States of AmericaA1
EP0927150B1European Patent Office (EPO)B1
AT215924TAustriaT
ATE215924T1AustriaT1
EP1201639A2European Patent Office (EPO)A2
DE69711894D1GermanyD1
US2002082435A1United States of AmericaA1
US2002091279A1United States of AmericaA1
DK0927150T3DenmarkT3
US2002111505A1United States of AmericaA1
PT927150EPortugalE
DE69711894T2GermanyT2
ES2175460T3SpainT3
EP1201639A3European Patent Office (EPO)A3
US2003032827A1United States of AmericaA1
US6569075B2United States of AmericaB2
CA2265708CCanadaC
US2003134901A1United States of AmericaA1
US6620919B2United States of AmericaB2
US6635776B2United States of AmericaB2
US6653493B2United States of AmericaB2
CA2164951CCanadaC
US6750360B2United States of AmericaB2
JP2005089472AJapanA
JP2005097314AJapanA
US6887901B1United States of AmericaB1
US2005148668A1United States of AmericaA1
US2006069158A1United States of AmericaA1
EP1657233A1European Patent Office (EPO)A1
US7288569B2United States of AmericaB2
US7294728B2United States of AmericaB2
JP4060366B2JapanB2
EP1201639B1European Patent Office (EPO)B1
AT404522TThis recordAustriaT
ATE404522T1AustriaT1
EP0703897B1European Patent Office (EPO)B1
AT405539TAustriaT
ATE405539T1AustriaT1
DE69738918D1GermanyD1
DE69435125D1GermanyD1
PT1201639EPortugalE
DK1201639T3DenmarkT3
PT703897EPortugalE
DK0703897T3DenmarkT3
ES2312499T3SpainT3
ES2313715T3SpainT3
JP2009073810AJapanA
EP2058293A1European Patent Office (EPO)A1
EP2107050A1European Patent Office (EPO)A1
US2009258945A1United States of AmericaA1
US2009270498A1United States of AmericaA1
US7741369B2United States of AmericaB2
US7825271B2United States of AmericaB2
JP4625310B2JapanB2
JP4625311B2JapanB2
JP2011148815AJapanA
JP4819847B2JapanB2
CA2448302CCanadaC
US2012277311A1United States of AmericaA1